Skip to main content

On 21 July, Barcelona will host a workshop on new trends in medical technology. The event, entitled Innovating in Medtech, Experiences from EU and USA, aims to serve as a bridge between the European and US markets to identify the differences in regulatory and reimbursement issues, which are key to marketing medtech products in each of these markets.

The workshop, organized by Biocat with collaboration from the European BILAT USA 2.0 project, is geared towards entrepreneurs, SMEs, start-ups, professionals in health innovation, hospital innovation managers and technology transfer professionals from the European Union and the United States. Participation is free of charge but those interested must register online before 20 July.

In line with the main aim of the workshop, the program will be structured around both local and foreign speakers, including presentations on market regulations and different medtech business models. Meike Bomhof, senior European associate at Hull Associates LLC and Moebio professor, will also discuss the reimbursement process and access to the American and European markets.

The event will finish off with case studies to see the role hospitals and research centers play in medtech innovation. There will be a total of six cases, four focusing on local projects – with participation from Hospital Sant Joan de Déu, Fundació Parc Taulí and Institut Guttmann, and form the company NEOS Surgery, explained by CEO Lluís Chico –. The other two projects will be from the USA market (Edison Nation Medical and Aperture Medical). 

The BILAT USA 2.0 project receives support from the European Union and aims to promote the development of science, technology and innovation through collaboration between Europe and the United States. The drastic increase in the medtech industry in the past year has motivated this event.

Studies show that the global medical technology market has been growing 5% each year since 2013, a trend that is expected to continue through 2020. The value this sector has acquired is due to its capacity to improve diagnostics and make surgery more efficient. And also because it helps shorten patient hospital stays, as they can be monitored and continue treatment outside the center.


With the support of:With the collaboration of:



Sign up for our newsletters

Stay up-to-date on the latest news, events and trends in the BioRegion.